Hadassah Medical Organization: Graft vs Host Disease trials

The registry lists 12 Graft vs Host Disease studies with Hadassah Medical Organization as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 6Phase 2 5Phase 3 3No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Vaginal Microbiome and the Development of Vulvovaginal Graft Versus Host DiseaseActive, not recruitingNCT05316740
• Vulvovaginal Graft Versus Host Disease (VV-GVHD) in Women Who Underwent Transplantation Before and After MenarcheCompletedNCT01512498
• Intra Arterial (IA) Steroids Infusion for Hepatic Acute Hepatic Graft Versus Host Disease (aGVHD)TerminatedNCT01140984Not applicable
• Allogeneic Mesenchymal Stem Cell for Graft-Versus-Host Disease TreatmentStatus unknownNCT00749164Phase 1/2
• Multi Donor Mismatched Stem Cell Transplantation (MDT)Status unknownNCT00716690Phase 1/2
• A Study to Evaluate the Effect of ATG-F on Engraftment, Graft Versus Host Disease (GVHD) and Graft Versus Leukemia (GVL) Effect in Haplo-identical SCTTerminatedNCT00616954Phase 3
• Open-Label Study Designed to Evaluate the Safety and Preliminary Efficacy of ApoCell for the Prevention of Acute GvHDStatus unknownNCT00524784Phase 1/2
• Safety Study of Preimplantation Factor (PIF-1) to Treat Acute Steroid-Resistant Graft-Versus-Host Disease (GVHD)Status unknownNCT00517907Phase 1
• Alefacept for Chronic Graft Versus Host DiseaseCompletedNCT00397332Phase 1/2
• Alefacept for Prevention of Graft Versus Host Disease (GVHD)TerminatedNCT00361413Phase 3
• Intra-Arterial Catheter Directed Therapy for Severe Graft vs. Host Disease (GVHD)CompletedNCT00146978Phase 1/2
• Thymoglobuline in Non-myeloablative Allogeneic Stem-cell TransplantationCompletedNCT00130754Phase 3